Your browser doesn't support javascript.
loading
Prognostic factors for the survival of patients with papillary renal cell carcinoma after surgical management.
Ren, W; Gao, X; Zhang, X; Hu, J; Li, H; Zu, X.
Afiliação
  • Ren W; Department of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Gao X; Department of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Zhang X; Department of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Hu J; Department of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Li H; Department of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Zu X; Department of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China. zuxbxyyy@126.com.
Clin Transl Oncol ; 22(5): 725-733, 2020 May.
Article em En | MEDLINE | ID: mdl-31317521
PURPOSE: To examine the possible prognostic factors in patients with type 1 and type 2 papillary renal cell carcinoma (pRCC) after surgical management and to identify the independent predictive factors of the prognosis. METHODS: From 2010 to 2017, 1405 patients underwent surgery for renal cell carcinoma, of whom 114 had type 1 or type 2 pRCC and follow-up data were available for 88 patients. Clinicopathological and prognostic parameters were compared between type 1 and type 2 pRCC. Possible prognostic factors were retrospectively analyzed by univariate and multivariate analyses with Cox regression. RESULTS: The study included 63 males and 25 females with a mean age of 54.27 ± 12.91. 53 patients were diagnosed by regular physical examination and others presented with hematuria or lumbago. 53 (60.2%) underwent radical nephrectomy and 35 (39.8%) underwent nephron sparing surgery. After a mean follow-up of 46.08 ± 22.65 months, 16 patients died of pRCC metastasis and the 5-year disease-specific survival was 79.3%. The comparison of the 39 (44.3%) type 1 and 49 (55.7%) type 2 pRCCs revealed that type 2 pRCC had significantly higher grade and worse prognosis. Univariate analysis showed that symptomatic diagnosis, type, grade, and tumor stage were prognostic factors. Multivariate analysis identified that type and tumor stage were independent factors of the prognosis. CONCLUSIONS: Pathological type and tumor stage could serve as independent factors for the prognosis of patients with pRCC.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Itália